Asthma trials in Austria

In Austria 12 Also abroad 500

12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
Innsbruck
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Where
Graz, Salzburg, St. Poelten
Age
6 years to 11 years
People
200 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Vienna
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
Phase 2Not yet taking people in Austria
A Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
Where
Vienna
Age
18 years and over
People
77 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
Where
Vienna
Age
18 years and over
People
121 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00
Phase 3Taking people
ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
Where
Innsbruck
People
94 worldwide
Run by
AstraZeneca AB
See details and how to join2025-523307-29-00 · EU 2025-523307-29-00
No phaseTaking people
Swiss Paediatric Airway Cohort
Where
Vienna
Age
0 years to 16 years
People
6,000 worldwide
Run by
University of Bern
See details and how to joinNCT03505216
No phaseNot yet taking people in Austria
Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps
Where
Vienna
Age
18 years to 99 years
People
20
Run by
Medical University of Vienna
See details and how to joinNCT07046117
No phaseTaking people
DETACT sEvere asThmAtiC paTients - a Pilot Study
Where
Vienna
Age
18 years and over
People
10
Run by
Medical University of Vienna
See details and how to joinNCT07025200
No phaseTaking people
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
Where
Vienna
Age
18 years to 99 years
People
30
Run by
Medical University of Vienna
See details and how to joinNCT05009758
Phase 4Taking people
TezeBarrier Study
Where
Vienna
Age
18 years and over
People
20
Run by
Medical University Of Vienna
See details and how to join2024-517538-16-00 · EU 2024-517538-16-00
No phaseTaking people
Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
Where
Innsbruck
Age
18 years and over
People
300
Run by
Medical University Innsbruck
See details and how to joinNCT04538937